October 2024

CARDIOVASCULAR

BEHIND BCVI: ENCOURAGING RESULTS FROM THE STEP-HFpEF-DM TRIAL

Featuring: Sanjiv J. Shah, MD, and Patrick M. McCarthy, MD​

Episode Summary

Patrick M. McCarthy, MD, interviews Sanjiv J. Shah, MD, on the groundbreaking results from the recent STEP-HFpEF-DM trial, including semaglutide use leading to over 70% reduction in heart failure hospitalization in patients with heart failure with preserved ejection fracture. Dr. Shah discusses the implications of these promising results and the future of using weight loss drugs to treat cardiovascular disease.

​Dr. McCarthy is executive director of Northwestern Medicine Bluhm Cardiovascular Institute, and Dr. Shah is director of Research for the Clinical Trials Unit at the institute.
​Sanjiv J. Shah, MD, Director, Institute for Artificial Intelligence in Medicine - Center for Deep Phenotyping and Precision Therapeutics, Neil J. Stone, MD, Professor, Professor of Medicine (Cardiology)
Patrick M. McCarthy, MD, ​Executive Director, Bluhm Cardiovascular Institute, Heller-Sacks Professor of Cardiothoracic Surgery, Professor, Surgery (Cardiac Surgery), Professor, McCormick School of Engineering

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you in caring for your patients. ​

You May Also Like